You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Misoprostol - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for misoprostol and what is the scope of patent protection?

Misoprostol is the generic ingredient in two branded drugs marketed by Pfizer, Acq Pharma, Ani Pharms, Micro Labs, and Novel Labs Inc, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for misoprostol. Sixteen suppliers are listed for this compound.

Summary for misoprostol
Drug Prices for misoprostol

See drug prices for misoprostol

Drug Sales Revenue Trends for misoprostol

See drug sales revenues for misoprostol

Recent Clinical Trials for misoprostol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Maryland, BaltimoreEarly Phase 1
Asfendiyarov Kazakh National Medical UniversityPhase 4
Kazakhstan's Medical University "KSPH"Phase 4

See all misoprostol clinical trials

Pharmacology for misoprostol
Medical Subject Heading (MeSH) Categories for misoprostol

US Patents and Regulatory Information for misoprostol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novel Labs Inc MISOPROSTOL misoprostol TABLET;ORAL 091667-001 Jul 25, 2012 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Micro Labs MISOPROSTOL misoprostol TABLET;ORAL 216872-002 Oct 17, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pfizer CYTOTEC misoprostol TABLET;ORAL 019268-001 Dec 27, 1988 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ani Pharms MISOPROSTOL misoprostol TABLET;ORAL 076095-002 Jul 10, 2002 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Micro Labs MISOPROSTOL misoprostol TABLET;ORAL 216872-001 Oct 17, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Acq Pharma MISOPROSTOL misoprostol TABLET;ORAL 210201-001 Jul 2, 2019 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for misoprostol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer CYTOTEC misoprostol TABLET;ORAL 019268-001 Dec 27, 1988 ⤷  Sign Up ⤷  Sign Up
Pfizer CYTOTEC misoprostol TABLET;ORAL 019268-003 Sep 21, 1990 ⤷  Sign Up ⤷  Sign Up
Pfizer CYTOTEC misoprostol TABLET;ORAL 019268-001 Dec 27, 1988 ⤷  Sign Up ⤷  Sign Up
Pfizer CYTOTEC misoprostol TABLET;ORAL 019268-001 Dec 27, 1988 ⤷  Sign Up ⤷  Sign Up
Pfizer CYTOTEC misoprostol TABLET;ORAL 019268-001 Dec 27, 1988 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.